Learn more at LeadIQ.com

Insights

Immunotherapy Advancements Innate Pharma is developing novel cell therapies and antibodies leveraging natural killer cells for treating various cancers. This innovative approach could present sales opportunities for partnering with hospitals and cancer treatment centers seeking advanced immunotherapy solutions.

Strategic Partnerships Innate Pharma has major collaborations with industry leaders like Bristol-Myers Squibb, Novo Nordisk, Sanofi, and AstraZeneca. Sales professionals can explore collaboration opportunities with these partners to expand the reach of the company's therapeutic antibodies and broaden market presence.

New Product Launches The recent launch of the NK cell engager SAR443579 / IPH6101 for treating blood cancers shows a commitment to product innovation. Sales teams can capitalize on the introduction of new products by targeting oncology clinics and medical institutions looking for advanced treatment options.

Financial Investment in Assets Innate Pharma made significant investments in property, plant, and equipment, indicating a focus on expanding infrastructure. This presents sales opportunities for companies in the construction, real estate, and facility management sectors looking to provide services to support the company's growth.

Market Expansion Plans With a broad pipeline of antibodies and a global presence, Innate Pharma is poised for market expansion. Sales professionals can explore opportunities in regions where the company aims to grow its presence, offering products and services tailored to local market needs.

Similar companies to Innate Pharma

Innate Pharma Tech Stack

Innate Pharma uses 8 technology products and services including FactSet, SAP, Cerner, and more. Explore Innate Pharma's tech stack below.

FactSet
Business Intelligence
SAP
Customer Relationship Management
Cerner
Electronic Health Records
Font Awesome
Font Scripts
HTTP/3
Miscellaneous
Microsoft
Miscellaneous
Adobe Creative Suite
Visualisation Software
ShareThis
Widgets

Media & News

Innate Pharma's Email Address Formats

Innate Pharma uses at least 1 format(s):

Innate Pharma Email Formats	Example	Percentage
First.Last@innate-pharma.com	John.Doe@innate-pharma.com	87%
First@innate-pharma.com	John@innate-pharma.com	6%
Last@innate-pharma.com	Doe@innate-pharma.com	4%
FLast@innate-pharma.com	JDoe@innate-pharma.com	3%

Frequently Asked Questions

Where is Innate Pharma's headquarters located?

Innate Pharma's main headquarters is located at 117, Avenue de Luminy Marseille, Provence-Alpes-Côte d’Azur 13009 FR. The company has employees across 6 continents, including EuropeAsiaNorth America.

What is Innate Pharma's phone number?

You can contact Innate Pharma's main corporate office by phone at +1-212-943-9478. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Innate Pharma's stock symbol?

Innate Pharma is a publicly traded company; the company's stock symbol is IPHA.

What is Innate Pharma's official website and social media links?

Innate Pharma's official website is innate-pharma.com and has social profiles on LinkedIn.

How much revenue does Innate Pharma generate?

As of July 2024, Innate Pharma's annual revenue reached $75M.

What is Innate Pharma's SIC code NAICS code?

Innate Pharma's SIC code is 7389 - Business Services, Not Elsewhere Classified NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Innate Pharma have currently?

As of July 2024, Innate Pharma has approximately 201 employees across 6 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officers Assistant: T. S.Chief Financial Officer: F. L.Chief Scientific Officer: E. V.. Explore Innate Pharma's employee directory with LeadIQ.

What industry does Innate Pharma belong to?

Innate Pharma operates in the Biotechnology Research industry.

What technology does Innate Pharma use?

Innate Pharma's tech stack includes FactSetSAPCernerFont AwesomeHTTP/3MicrosoftAdobe Creative SuiteShareThis.

What is Innate Pharma's email format?

Innate Pharma's email format typically follows the pattern of . Find more Innate Pharma email formats with LeadIQ.

How much funding has Innate Pharma raised to date?

As of July 2024, Innate Pharma has raised $75M in funding. The last funding round occurred on May 02, 2022.

When was Innate Pharma founded?

Innate Pharma was founded in 1999.

Innate Pharma

Innate Pharma

Biotechnology ResearchProvence-Alpes-Côte d’Azur, France201-500 Employees

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.

Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.

Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.

Company Overview

Headquarters: 117, Avenue de Luminy Marseille, Provence-Alpes-Côte d’Azur 13009 FR
Phone number: +1-212-943-9478
Website: innate-pharma.com
SIC Code: 7389 - Business Services, Not Elsewhere Classified
Stock Symbol: IPHA
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 1999
Employees: 201-500

Media & News

Funding & Financials

$75M
Innate Pharma has raised a total of $75M of funding over 8 rounds. Their latest funding round was raised on May 02, 2022.
$50M$100M
Innate Pharma's revenue is in the range of $50M$100M

Funding & Financials

$75M
Innate Pharma has raised a total of $75M of funding over 8 rounds. Their latest funding round was raised on May 02, 2022.
$50M$100M
Innate Pharma's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.